JP2007504284A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504284A5
JP2007504284A5 JP2006533807A JP2006533807A JP2007504284A5 JP 2007504284 A5 JP2007504284 A5 JP 2007504284A5 JP 2006533807 A JP2006533807 A JP 2006533807A JP 2006533807 A JP2006533807 A JP 2006533807A JP 2007504284 A5 JP2007504284 A5 JP 2007504284A5
Authority
JP
Japan
Prior art keywords
halo
compound according
compound
alkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006533807A
Other languages
English (en)
Japanese (ja)
Other versions
JP5269315B2 (ja
JP2007504284A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/019189 external-priority patent/WO2005004866A1/en
Publication of JP2007504284A publication Critical patent/JP2007504284A/ja
Publication of JP2007504284A5 publication Critical patent/JP2007504284A5/ja
Application granted granted Critical
Publication of JP5269315B2 publication Critical patent/JP5269315B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2006533807A 2003-06-12 2004-06-14 疼痛を治療するのに有用な治療薬 Expired - Fee Related JP5269315B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47774403P 2003-06-12 2003-06-12
US60/477,744 2003-06-12
PCT/US2004/019189 WO2005004866A1 (en) 2003-06-12 2004-06-14 Therapeutic agents useful for treating pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011159464A Division JP2012021000A (ja) 2003-06-12 2011-07-21 疼痛を治療するのに有用な治療薬

Publications (3)

Publication Number Publication Date
JP2007504284A JP2007504284A (ja) 2007-03-01
JP2007504284A5 true JP2007504284A5 (US07094801-20060822-C00072.png) 2011-09-08
JP5269315B2 JP5269315B2 (ja) 2013-08-21

Family

ID=34061917

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006533807A Expired - Fee Related JP5269315B2 (ja) 2003-06-12 2004-06-14 疼痛を治療するのに有用な治療薬
JP2011159464A Withdrawn JP2012021000A (ja) 2003-06-12 2011-07-21 疼痛を治療するのに有用な治療薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011159464A Withdrawn JP2012021000A (ja) 2003-06-12 2011-07-21 疼痛を治療するのに有用な治療薬

Country Status (28)

Country Link
US (3) US7683063B2 (US07094801-20060822-C00072.png)
EP (3) EP2060260A1 (US07094801-20060822-C00072.png)
JP (2) JP5269315B2 (US07094801-20060822-C00072.png)
KR (2) KR100896497B1 (US07094801-20060822-C00072.png)
CN (2) CN1835751B (US07094801-20060822-C00072.png)
AR (1) AR044688A1 (US07094801-20060822-C00072.png)
AT (2) ATE369133T1 (US07094801-20060822-C00072.png)
AU (1) AU2004255169B2 (US07094801-20060822-C00072.png)
BR (1) BRPI0411241A (US07094801-20060822-C00072.png)
CA (1) CA2528920C (US07094801-20060822-C00072.png)
CY (1) CY1108738T1 (US07094801-20060822-C00072.png)
DE (2) DE602004008069D1 (US07094801-20060822-C00072.png)
DK (1) DK1862458T3 (US07094801-20060822-C00072.png)
EA (1) EA009593B1 (US07094801-20060822-C00072.png)
ES (1) ES2317623T3 (US07094801-20060822-C00072.png)
GE (1) GEP20084488B (US07094801-20060822-C00072.png)
IL (1) IL172418A (US07094801-20060822-C00072.png)
IS (1) IS8142A (US07094801-20060822-C00072.png)
MA (1) MA27908A1 (US07094801-20060822-C00072.png)
MX (1) MXPA05013587A (US07094801-20060822-C00072.png)
MY (1) MY142655A (US07094801-20060822-C00072.png)
NO (1) NO20060192L (US07094801-20060822-C00072.png)
PL (1) PL1862458T3 (US07094801-20060822-C00072.png)
PT (1) PT1862458E (US07094801-20060822-C00072.png)
SI (1) SI1862458T1 (US07094801-20060822-C00072.png)
TW (1) TWI287010B (US07094801-20060822-C00072.png)
WO (1) WO2005004866A1 (US07094801-20060822-C00072.png)
ZA (1) ZA200508744B (US07094801-20060822-C00072.png)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4077320B2 (ja) 2001-01-29 2008-04-16 塩野義製薬株式会社 5−メチル−1−フェニル−2−(1h)−ピリドンを有効成分として含有する医薬製剤
ATE556067T1 (de) 2003-05-20 2012-05-15 Ajinomoto Kk Modulatoren des vanilloid rezeptors
TWI287010B (en) * 2003-06-12 2007-09-21 Euro Celtique Sa Therapeutic agents useful for treating pain
US20050009841A1 (en) * 2003-07-11 2005-01-13 Zheng Guo Zhu Novel amides useful for treating pain
DE602004017316D1 (de) * 2003-07-24 2008-12-04 Euro Celtique Sa Heteroaryl-tetrahydropyridylverbindungen, die sich für die behandlung bzw. die prävention von schmerzen eignen
ES2326979T3 (es) * 2003-07-24 2009-10-22 Euro-Celtique S.A. Compuestos de piperidina y composiciones farmaceuticas que contienen a los mismos.
TW200738232A (en) * 2006-01-31 2007-10-16 Alcon Mfg Ltd Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
KR100801278B1 (ko) * 2006-08-29 2008-02-04 삼성전기주식회사 하이브리드형 광도파로 센서
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
WO2008057300A2 (en) * 2006-10-27 2008-05-15 Redpoint Bio Corporation Trpvi antagonists and uses thereof
MX2009011601A (es) * 2007-04-27 2009-11-10 Purdue Pharma Lp Agentes terapeuticos utiles para tratar el dolor.
MY148657A (en) 2007-04-27 2013-05-15 Purdue Pharma Lp Trpv1 antagonists and uses thereof
ES2398606T3 (es) 2007-05-03 2013-03-20 Pfizer Limited Derivados de 2-piridin-carboxamida como moduladores de los canales de sodio
EP2185538A2 (en) * 2007-08-09 2010-05-19 Abbott Laboratories Tetrahydropyridine carboxamide derivatives as trpvl antagonists
US8084616B2 (en) 2007-10-24 2011-12-27 Abbott Laboratories TRPV1 antagonists
RU2496494C2 (ru) 2008-06-30 2013-10-27 Новартис Аг КОМБИНАЦИИ, СОДЕРЖАЩИЕ МОДУЛЯТОРЫ mGluR, ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ ПАРКИНСОНА
EP2585446A4 (en) 2010-06-22 2013-12-25 Shionogi & Co COMPOUNDS WITH ANTAGONISTIC EFFECT AGAINST TRPV1 AND THEIR USE
WO2012158844A1 (en) 2011-05-17 2012-11-22 Shionogi & Co., Ltd. Heterocyclic compounds
MY185061A (en) 2011-06-22 2021-04-30 Shionogi & Co Trpv1 antagonists including dihydroxy substituent and uses thereof
WO2013146970A1 (ja) * 2012-03-29 2013-10-03 第一三共株式会社 新規キノリン誘導体
US9938265B2 (en) * 2015-11-30 2018-04-10 Astrazeneca Ab 1,3,4-thiadiazole compounds and their use in treating cancer
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN109561680B (zh) * 2016-06-23 2021-07-13 圣朱德儿童研究医院 泛酸激酶的小分子调节剂
GB201709459D0 (en) * 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine
JP6964506B2 (ja) * 2017-12-19 2021-11-10 ライオン株式会社 錠剤及び錠剤の製造方法
CA3086671A1 (en) 2017-12-27 2019-07-04 St. Jude Children's Research Hospital, Inc. Small molecule modulators of pantothenate kinases
CA3086711A1 (en) 2017-12-27 2019-07-04 St. Jude Children's Research Hospital, Inc. Methods of treating disorders associated with castor
RU2744162C1 (ru) * 2020-03-18 2021-03-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермская государственная фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ПГФА Минздрава России) Анальгетическое средство на основе 5-(2-аминопропил)-6-оксо-3,4-дифенилпирроло[3,4-c]пиразола
CN113061593B (zh) * 2021-04-02 2023-11-10 洛阳华荣生物技术有限公司 一种l-苹果酸脱氢酶突变体及其应用
DE102022104759A1 (de) 2022-02-28 2023-08-31 SCi Kontor GmbH Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen
CN114957214A (zh) * 2022-06-22 2022-08-30 九江善水科技股份有限公司 一种氯虫苯甲酰胺中间体的制备方法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
GB1363215A (en) * 1973-01-04 1974-08-14 Mullard Ltd Mechanical-electrical transducer
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US5053595A (en) * 1982-12-01 1991-10-01 Metcal, Inc. Heat shrink sleeve with high mu material
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JPH0680054B2 (ja) 1985-06-19 1994-10-12 吉富製薬株式会社 ピペリジン誘導体
US5316759A (en) 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US5198459A (en) 1987-07-11 1993-03-30 Sandoz Ltd. Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
DE3822792C2 (de) 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5075341A (en) 1989-12-01 1991-12-24 The Mclean Hospital Corporation Treatment for cocaine abuse
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
ATE156823T1 (de) * 1990-06-07 1997-08-15 Zeneca Ltd Therapeutische heterocyclische verbindungen
FR2676734B1 (fr) 1991-05-23 1995-05-19 Roussel Uclaf Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US6204284B1 (en) 1991-12-20 2001-03-20 American Cyanamid Company Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5232934A (en) 1992-07-17 1993-08-03 Warner-Lambert Co. Method for the treatment of psychomotor stimulant addiction
DE4234295A1 (de) 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5321012A (en) 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5556837A (en) 1994-08-01 1996-09-17 Regeneron Pharmaceuticals Inc. Methods for treating addictive disorders
US5762925A (en) 1994-11-03 1998-06-09 Sagen; Jacqueline Preventing opiate tolerance by cellular implantation
AU6111796A (en) 1995-06-12 1997-01-09 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5 -lipoxygenase inhibitor
US6063930A (en) 1996-04-03 2000-05-16 Merck & Co., Inc. Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
CA2274593A1 (en) 1996-12-13 1998-06-18 Banyu Pharmaceutical Co., Ltd. Novel aminopyrazole derivatives
US6703362B1 (en) 1997-05-15 2004-03-09 Cytogen Corporation Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
WO1999009140A1 (en) 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
EP0943683A1 (en) 1998-03-10 1999-09-22 Smithkline Beecham Plc Human vanilloid receptor homologue Vanilrep1
US6098369A (en) * 1998-07-17 2000-08-08 Bodolay; William A. Apparatus for attaching a reclosable fastener to a flexible material
DE69919212T2 (de) 1998-12-23 2005-07-28 Eli Lilly And Co., Indianapolis Aromatische amiden
US6689780B1 (en) 1998-12-23 2004-02-10 Eli Lilly And Company Heteroroaromatic amides as inhibitor of factor Xa
ATE240316T1 (de) * 1998-12-23 2003-05-15 Lilly Co Eli Heteroaromatische amide als inhibitoren von faktor xa
GB9907097D0 (en) 1999-03-26 1999-05-19 Novartis Ag Organic compounds
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
EP1272187B1 (de) 2000-03-27 2008-07-30 Abbott GmbH & Co. KG Dopamin-d3-rezeptor-liganden zur behandlung von sucht
WO2001082925A1 (fr) 2000-04-28 2001-11-08 Takeda Chemical Industries, Ltd. Antagonistes de l'hormone concentrant la melanine
AR028782A1 (es) * 2000-07-05 2003-05-21 Taisho Pharmaceutical Co Ltd Derivados heterociclicos tetrahidropiridino o piperidino
JP2003142681A (ja) 2001-10-31 2003-05-16 Sony Corp 絶縁ゲート型電界効果トランジスタを有する半導体装置
JP2003192673A (ja) 2001-12-27 2003-07-09 Bayer Ag ピペラジンカルボキシアミド誘導体
PT1472225E (pt) * 2002-02-01 2010-07-30 Euro Celtique Sa 2-piperazina-piridinas uteis para tratar a dor
AR038420A1 (es) 2002-02-15 2005-01-12 Glaxo Group Ltd Compuesto de amida, procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
WO2004035549A1 (en) 2002-10-17 2004-04-29 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
WO2004080411A2 (en) 2003-03-07 2004-09-23 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
US20050014753A1 (en) 2003-04-04 2005-01-20 Irm Llc Novel compounds and compositions as protein kinase inhibitors
ATE556067T1 (de) * 2003-05-20 2012-05-15 Ajinomoto Kk Modulatoren des vanilloid rezeptors
TWI287010B (en) 2003-06-12 2007-09-21 Euro Celtique Sa Therapeutic agents useful for treating pain
US7129235B2 (en) * 2003-07-11 2006-10-31 Abbott Laboratories Amides useful for treating pain
US20050009841A1 (en) * 2003-07-11 2005-01-13 Zheng Guo Zhu Novel amides useful for treating pain
ES2326979T3 (es) * 2003-07-24 2009-10-22 Euro-Celtique S.A. Compuestos de piperidina y composiciones farmaceuticas que contienen a los mismos.
DE602004017316D1 (de) * 2003-07-24 2008-12-04 Euro Celtique Sa Heteroaryl-tetrahydropyridylverbindungen, die sich für die behandlung bzw. die prävention von schmerzen eignen
MX2009011601A (es) * 2007-04-27 2009-11-10 Purdue Pharma Lp Agentes terapeuticos utiles para tratar el dolor.

Similar Documents

Publication Publication Date Title
JP2007504284A5 (US07094801-20060822-C00072.png)
JP6506836B2 (ja) B型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン
JP2019510787A5 (US07094801-20060822-C00072.png)
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
KR910004430B1 (ko) 5-피리딜-1,3-티아졸 유도체의 제조방법
JP2006528643A5 (US07094801-20060822-C00072.png)
JP2002529532A5 (US07094801-20060822-C00072.png)
JP2005504789A5 (US07094801-20060822-C00072.png)
JP3162721B2 (ja) 新規チアゾリジンジオン及びそれを含有する医薬製剤
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
JP2003503387A5 (US07094801-20060822-C00072.png)
JP2003521542A (ja) チアゾリジンカルボン酸誘導体及び癌の治療におけるその利用
JP2001526220A5 (US07094801-20060822-C00072.png)
JP2012021003A5 (US07094801-20060822-C00072.png)
TW200528097A (en) Novel thiazolidin-4-one derivatives
JP2003519154A5 (US07094801-20060822-C00072.png)
JP2018135343A5 (US07094801-20060822-C00072.png)
JP2001526269A5 (US07094801-20060822-C00072.png)
JP2006507355A5 (US07094801-20060822-C00072.png)
KR20080034436A (ko) 암 치료에 사용되는 티아졸 유도체 및 유사체
JP2010540593A5 (US07094801-20060822-C00072.png)
JP2009538309A5 (US07094801-20060822-C00072.png)
JPWO2010029925A1 (ja) 新規なプロスタグランジンi2誘導体
JPWO2019148044A5 (US07094801-20060822-C00072.png)
KR100608416B1 (ko) 2-(n-시아노이미노)티아졸리딘-4-온 유도체